Why the study?
This review examines cardiovascular involvement in various nephrological diseases commonly seen in clinical practice, focusing on types 3-5 CRS in children from a nephrology perspective.
Population
Children with types 3-5 CRS or nephrological diseases
Design
Review
Key result
Cardiorenal syndrome types 3 to 5 in children pose a significant mortality risk, highlighting a critical need for longitudinal studies, specific biomarkers, and targeted therapies to improve outcomes.
Authors
Loading...
High mortality in pediatric cardiorenal syndrome types 3-5 should not yet change practice; leaves open needs for longitudinal studies, biomarkers, and therapies.
This review emphasizes the critical gaps in diagnosing and managing cardiorenal syndrome in pediatric patients, highlighting the need for new biomarkers and collaborative, large-scale studies.
Leventoğlu et al. (2025) conducted a review in Cardiorenal syndrome (types 3-5). Cardiorenal syndrome types 3 to 5 in children pose a significant mortality risk, highlighting a critical need for longitudinal studies, specific biomarkers, and targeted therapies to improve outcomes.